Sai Parenterals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
SAIPARENT · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Sai Parenterals Limited has announced the closure of its trading window for designated persons and their immediate relatives, effective April 02, 2026. The trading window will remain shut until 48 hours after the conclusion of a Board of Directors meeting. This Board meeting is being convened to consider the Unaudited Financial Results for Q3 FY2025-26 (quarter ended December 31, 2025) and Audited Financial Results for Q4 and full year ended March 31, 2026. The specific date of the Board Meeting will be communicated separately. This is a standard compliance requirement under SEBI Insider Trading Regulations to prevent misuse of unpublished price-sensitive information.
This is a routine regulatory filing with no direct impact on the stock. However, it signals that a Board meeting to approve financial results is imminent, which could lead to increased volatility once the trading window reopens after the results are announced.